Cargando…
How minimally interrupted direct oral anticoagulants affect intraprocedural anticoagulation during atrial fibrillation ablation? Insights from a Japanese single‐center retrospective study
BACKGROUND: Data are still lacking regarding the effects of minimally interrupted direct oral anticoagulants (MID) on the intensity of intraprocedural anticoagulation of atrial fibrillation (AF) ablation. METHODS: A total of consecutive 269 patients who undergone AF ablation were eligible for the st...
Autores principales: | Mizobuchi, Masahiro, Funatsu, Atsushi, Kobayashi, Tomoko, Nakamura, Shigeru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6786984/ https://www.ncbi.nlm.nih.gov/pubmed/31624510 http://dx.doi.org/10.1002/joa3.12228 |
Ejemplares similares
-
Atrial Fibrillation Ablation without Interruption of
Anticoagulation
por: Santangeli, Pasquale, et al.
Publicado: (2011) -
Unrecognized left atrial activation patterns of Marshall bundle–related atrial tachycardia following atrial fibrillation ablation
por: Mizobuchi, Masahiro, et al.
Publicado: (2020) -
Minimally interrupted novel oral anticoagulant versus uninterrupted vitamin K antagonist during atrial fibrillation ablation
por: De Heide, John, et al.
Publicado: (2018) -
Activated clotting time on the day of atrial fibrillation ablation for minimally interrupted and uninterrupted direct oral anticoagulation therapy: Sequential changes, differences among direct oral anticoagulants, and ablation safety outcomes
por: Yamaji, Hirosuke, et al.
Publicado: (2019) -
Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban
por: Winkle, Roger A., et al.
Publicado: (2014)